141 related articles for article (PubMed ID: 10086658)
1. Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective?
Breuer T; Graham DY
Am J Gastroenterol; 1999 Mar; 94(3):725-9. PubMed ID: 10086658
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Romano M; Marmo R; Cuomo A; De Simone T; Mucherino C; Iovene MR; Montella F; Tufano MA; Del Vecchio Blanco C; Nardone G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):273-8. PubMed ID: 15017668
[TBL] [Abstract][Full Text] [Related]
3. Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis.
Fendrick AM; Chernew ME; Hirth RA; Bloom BS
Yale J Biol Med; 1996; 69(2):187-95. PubMed ID: 9112750
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Helicobacter pylori "test and treat" for patients with typical reflux symptoms in a population with a high prevalence of H. pylori infection: a Markov model analysis.
You JH; Wong PL; Wu JC
Scand J Gastroenterol; 2006 Jan; 41(1):21-9. PubMed ID: 16373272
[TBL] [Abstract][Full Text] [Related]
5. How to treat Helicobacter pylori infection--should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint.
de Boer WA; Tytgat GN
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):709-16. PubMed ID: 8853263
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of diagnostic testing strategies for Helicobacter pylori.
Vakil N; Rhew D; Soll A; Ofman JJ
Am J Gastroenterol; 2000 Jul; 95(7):1691-8. PubMed ID: 10925969
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of noninvasive testing and treatment strategies for H. pylori infection in children with dyspepsia.
Vakil N; Ashorn M
Am J Gastroenterol; 1998 Apr; 93(4):562-8. PubMed ID: 9576448
[TBL] [Abstract][Full Text] [Related]
8. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
[TBL] [Abstract][Full Text] [Related]
9. Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease.
Wongkusoltham P; Vilaichone RK; Kullavanijaya P; Phaosawadi K; Mahachai V
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S474-80. PubMed ID: 11529378
[TBL] [Abstract][Full Text] [Related]
10. Management strategies for duodenal ulcer in India in the helicobacter pylori era: an economic analysis.
Ghoshal UC; Das A
Natl Med J India; 2002; 15(3):140-4. PubMed ID: 12186326
[TBL] [Abstract][Full Text] [Related]
11. The health economics of Helicobacter pylori infection.
Moayyedi P
Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Helicobacter pylori infection in patients with duodenal ulcer: a cost-benefit study].
Rollán A; Giancaspero R; Acevedo C; Fuster F; Hola K
Rev Med Chil; 2000 Apr; 128(4):367-77. PubMed ID: 10962853
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting.
Klok RM; Arents NL; de Vries R; Thijs JC; Brouwers JR; Kleibeuker JH; Postma MJ
Clin Ther; 2005 Oct; 27(10):1647-57. PubMed ID: 16330302
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori-associated ulcer bleeding: should we test for eradication after treatment?
Pohl H; Finlayson SR; Sonnenberg A; Robertson DJ
Aliment Pharmacol Ther; 2005 Sep; 22(6):529-37. PubMed ID: 16167969
[TBL] [Abstract][Full Text] [Related]
16. The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage.
Ofman J; Wallace J; Badamgarav E; Chiou CF; Henning J; Laine L
Am J Gastroenterol; 2002 Aug; 97(8):1941-50. PubMed ID: 12190158
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive tests as a substitute for histology in the diagnosis of Helicobacter pylori infection.
Hahn M; Fennerty MB; Corless CL; Magaret N; Lieberman DA; Faigel DO
Gastrointest Endosc; 2000 Jul; 52(1):20-6. PubMed ID: 10882957
[TBL] [Abstract][Full Text] [Related]
18. Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients.
Vakil N; Zullo A; Ricci C; Hassan C; Vaira D
Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1304-8. PubMed ID: 18774949
[TBL] [Abstract][Full Text] [Related]
19. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
[TBL] [Abstract][Full Text] [Related]
20. Evolving therapy for Helicobacter pylori infection: efficacy and economic impact in the treatment of patients with duodenal ulcer disease.
Cutler AF; Vakil N
Am J Manag Care; 1997 Oct; 3(10):1528-34. PubMed ID: 10178459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
